190 related articles for article (PubMed ID: 33095052)
1. Reproducible Antigen Recognition by the Type I-F CRISPR-Cas System.
Wiegand T; Semenova E; Shiriaeva A; Fedorov I; Datsenko K; Severinov K; Wiedenheft B
CRISPR J; 2020 Oct; 3(5):378-387. PubMed ID: 33095052
[TBL] [Abstract][Full Text] [Related]
2. Cas1 and Cas2 From the Type II-C CRISPR-Cas System of
He Y; Wang M; Liu M; Huang L; Liu C; Zhang X; Yi H; Cheng A; Zhu D; Yang Q; Wu Y; Zhao X; Chen S; Jia R; Zhang S; Liu Y; Yu Y; Zhang L
Front Cell Infect Microbiol; 2018; 8():195. PubMed ID: 29951376
[TBL] [Abstract][Full Text] [Related]
3. Structure Reveals a Mechanism of CRISPR-RNA-Guided Nuclease Recruitment and Anti-CRISPR Viral Mimicry.
Rollins MF; Chowdhury S; Carter J; Golden SM; Miettinen HM; Santiago-Frangos A; Faith D; Lawrence CM; Lander GC; Wiedenheft B
Mol Cell; 2019 Apr; 74(1):132-142.e5. PubMed ID: 30872121
[TBL] [Abstract][Full Text] [Related]
4. Foreign DNA acquisition by the I-F CRISPR-Cas system requires all components of the interference machinery.
Vorontsova D; Datsenko KA; Medvedeva S; Bondy-Denomy J; Savitskaya EE; Pougach K; Logacheva M; Wiedenheft B; Davidson AR; Severinov K; Semenova E
Nucleic Acids Res; 2015 Dec; 43(22):10848-60. PubMed ID: 26586803
[TBL] [Abstract][Full Text] [Related]
5. How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration.
Xiao Y; Ng S; Nam KH; Ke A
Nature; 2017 Oct; 550(7674):137-141. PubMed ID: 28869593
[TBL] [Abstract][Full Text] [Related]
6. Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance.
Pausch P; Müller-Esparza H; Gleditzsch D; Altegoer F; Randau L; Bange G
Mol Cell; 2017 Aug; 67(4):622-632.e4. PubMed ID: 28781236
[TBL] [Abstract][Full Text] [Related]
7. Requirements for Pseudomonas aeruginosa Type I-F CRISPR-Cas Adaptation Determined Using a Biofilm Enrichment Assay.
Heussler GE; Miller JL; Price CE; Collins AJ; O'Toole GA
J Bacteriol; 2016 Nov; 198(22):3080-3090. PubMed ID: 27573013
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-spacer integration reporter plasmids reveal distinct genuine acquisition specificities among CRISPR-Cas I-E variants of Escherichia coli.
Díez-Villaseñor C; Guzmán NM; Almendros C; García-Martínez J; Mojica FJ
RNA Biol; 2013 May; 10(5):792-802. PubMed ID: 23445770
[TBL] [Abstract][Full Text] [Related]
9. Processing and integration of functionally oriented prespacers in the
Ramachandran A; Summerville L; Learn BA; DeBell L; Bailey S
J Biol Chem; 2020 Mar; 295(11):3403-3414. PubMed ID: 31914418
[TBL] [Abstract][Full Text] [Related]
10. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of foreign DNA recognition by a CRISPR RNA-guided surveillance complex from Pseudomonas aeruginosa.
Rollins MF; Schuman JT; Paulus K; Bukhari HS; Wiedenheft B
Nucleic Acids Res; 2015 Feb; 43(4):2216-22. PubMed ID: 25662606
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric positioning of Cas1-2 complex and Integration Host Factor induced DNA bending guide the unidirectional homing of protospacer in CRISPR-Cas type I-E system.
Yoganand KN; Sivathanu R; Nimkar S; Anand B
Nucleic Acids Res; 2017 Jan; 45(1):367-381. PubMed ID: 27899566
[TBL] [Abstract][Full Text] [Related]
13. Cas4-Dependent Prespacer Processing Ensures High-Fidelity Programming of CRISPR Arrays.
Lee H; Zhou Y; Taylor DW; Sashital DG
Mol Cell; 2018 Apr; 70(1):48-59.e5. PubMed ID: 29602742
[TBL] [Abstract][Full Text] [Related]
14. Integrase-mediated spacer acquisition during CRISPR-Cas adaptive immunity.
Nuñez JK; Lee AS; Engelman A; Doudna JA
Nature; 2015 Mar; 519(7542):193-8. PubMed ID: 25707795
[TBL] [Abstract][Full Text] [Related]
15. Fidelity of prespacer capture and processing is governed by the PAM-mediated interactions of Cas1-2 adaptation complex in CRISPR-Cas type I-E system.
Yoganand KN; Muralidharan M; Nimkar S; Anand B
J Biol Chem; 2019 Dec; 294(52):20039-20053. PubMed ID: 31748409
[TBL] [Abstract][Full Text] [Related]
16. Approaches to study CRISPR RNA biogenesis and the key players involved.
Behler J; Hess WR
Methods; 2020 Feb; 172():12-26. PubMed ID: 31325492
[TBL] [Abstract][Full Text] [Related]
17. Spacer-length DNA intermediates are associated with Cas1 in cells undergoing primed CRISPR adaptation.
Musharova O; Klimuk E; Datsenko KA; Metlitskaya A; Logacheva M; Semenova E; Severinov K; Savitskaya E
Nucleic Acids Res; 2017 Apr; 45(6):3297-3307. PubMed ID: 28204574
[TBL] [Abstract][Full Text] [Related]
18. CRISPR RNA binding and DNA target recognition by purified Cascade complexes from Escherichia coli.
Beloglazova N; Kuznedelov K; Flick R; Datsenko KA; Brown G; Popovic A; Lemak S; Semenova E; Severinov K; Yakunin AF
Nucleic Acids Res; 2015 Jan; 43(1):530-43. PubMed ID: 25488810
[TBL] [Abstract][Full Text] [Related]
19. A Type I-F Anti-CRISPR Protein Inhibits the CRISPR-Cas Surveillance Complex by ADP-Ribosylation.
Niu Y; Yang L; Gao T; Dong C; Zhang B; Yin P; Hopp AK; Li D; Gan R; Wang H; Liu X; Cao X; Xie Y; Meng X; Deng H; Zhang X; Ren J; Hottiger MO; Chen Z; Zhang Y; Liu X; Feng Y
Mol Cell; 2020 Nov; 80(3):512-524.e5. PubMed ID: 33049228
[TBL] [Abstract][Full Text] [Related]
20. CRISPR RNA and anti-CRISPR protein binding to the
Hong S; Ka D; Yoon SJ; Suh N; Jeong M; Suh JY; Bae E
J Biol Chem; 2018 Feb; 293(8):2744-2754. PubMed ID: 29348170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
